We are back to the old "clear path" scenario. Its much easier for the wonks to build entity valuation models now that the financing and enrollment challenges are off the table. You may recall, mnkd went over $11/share leading up to last pdufa. With roughly twice as many shares outstanding (somewhat offset by prospect of an expanded label) it should chart a jagged line to the $6 range.

I think many of us that have been tracking this company for so many years (7?) have a jaded view. I'm sure the prospects look quite different for folks that started following after latest round of financing.

All that being said, I would not be surprised if we revisited sub $1.80's as some here have projected.